- Press release of the University of Vienna (in German): 19 April 2018: Neuer Wirkmechanismus von Tumortherapeutikum entdeckt
- Press release published by Intezyne:13 April 2018: Data Showing that IT-139 Triggers Immunogenic Cell Death (ICD) to Be Presented at AACR 2018 Annual Meeting
- Press release, 20 Juli 2017: Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer
- Website Intezyne: IT-139
New mechanism of action of tumour therapy discovered
19.04.2018